3.4.1 Demonstrate knowledge about the risks and opportunities associated with drug discontinuation and methodologies for individualized implementation (L2)

Subscribe to the ILAE Newsletter

To subscribe, please click on the button below.

Please send me information about ILAE activities and other
information of interest to the epilepsy community